TOPIRAMATE

Product NDC: 31722-550
11-digit product format: 317220550
Labeler code: 31722
Product ID: 31722-550_c4f0c0d0-430f-4c9d-96f0-8c90f6af31e8
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Topiramate
Dosage form: CAPSULE, EXTENDED RELEASE
Route: ORAL
Labeler: Camber Pharmaceuticals, Inc.
Application: ANDA217443
Marketing category: ANDA
Marketing start: 2026-04-01
Substance: TOPIRAMATE
Active strength: 200 mg/1
Pharmacologic classes: Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A217443-001	TOPIRAMATE	TOPIRAMATE	25MG	CAPSULE, EXTENDED RELEASE / ORAL	AB1	2026-01-12
A217443-002	TOPIRAMATE	TOPIRAMATE	50MG	CAPSULE, EXTENDED RELEASE / ORAL	AB1	2026-01-12
A217443-003	TOPIRAMATE	TOPIRAMATE	100MG	CAPSULE, EXTENDED RELEASE / ORAL	AB1	2026-01-12
A217443-004	TOPIRAMATE	TOPIRAMATE	200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB1	2026-01-12

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A217443-001	AB1
A217443-002	AB1
A217443-003	AB1
A217443-004	AB1

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A217443-001	TOPIRAMATE	25MG	CAPSULE, EXTENDED RELEASE / ORAL	AB1	2026-01-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A217443-002	TOPIRAMATE	50MG	CAPSULE, EXTENDED RELEASE / ORAL	AB1	2026-01-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A217443-003	TOPIRAMATE	100MG	CAPSULE, EXTENDED RELEASE / ORAL	AB1	2026-01-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A217443-004	TOPIRAMATE	200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB1	2026-01-12	`011fe1cb6892…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A217443-001	TOPIRAMATE	25MG	CAPSULE, EXTENDED RELEASE / ORAL	AB1	2026-01-12	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A217443-002	TOPIRAMATE	50MG	CAPSULE, EXTENDED RELEASE / ORAL	AB1	2026-01-12	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A217443-003	TOPIRAMATE	100MG	CAPSULE, EXTENDED RELEASE / ORAL	AB1	2026-01-12	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A217443-004	TOPIRAMATE	200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB1	2026-01-12	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A217443-001	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A217443-002	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A217443-003	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A217443-004	AB1	1	`011fe1cb6892…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A217443-001	AB1	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A217443-002	AB1	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A217443-003	AB1	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A217443-004	AB1	1	`a50c72e98297…`

Additional Listing Data#

Finished product: Yes
Brand name base: TOPIRAMATE
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
TOPIRAMATE	200 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
0H73WJJ391	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1436239	Internal RxNorm lookup
1437278	Internal RxNorm lookup
1437283	Internal RxNorm lookup
1437288	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
dbc52b16-b93d-4d83-942b-485c502db1fa	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
e5b1b0ba-27f8-4d5d-8943-8aed080fdedc	Product name	4	20260306
6c26dd6d-01b5-4a80-b096-b3a6f7ca6077	Product name	2	20250623
cb966f54-bbf0-40fb-b581-80c6648d510c	Product name	4	20250623
6e2fb0d7-40d7-e97c-1375-fa022ff20193	Product name	4	20250305
3d272a3f-17c0-421d-bc43-3cbdb719258d	Product name	1	20250303

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
31722-550-30	TOPIRAMATE	30 in 1 BOTTLE	CAPSULE, EXTENDED RELEASE	30		1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TOPIRAMATE	TOPIRAMATE	Camber Pharmaceuticals, Inc.	dbc52b16-b93d-4d83-942b-485c502db1fa	2026-03-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 217443 application number: ANDA217443 ndc (product): 31722-550

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
0H73WJJ391	TOPIRAMATE	97240-79-4	TOPIRAMATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1437283	topiramate 100 MG 24HR Extended Release Oral Capsule	PSN	dbc52b16-b93d-4d83-942b-485c502db1fa	1
1437288	topiramate 200 MG 24HR Extended Release Oral Capsule	PSN	dbc52b16-b93d-4d83-942b-485c502db1fa	1
1437278	topiramate 25 MG 24HR Extended Release Oral Capsule	PSN	dbc52b16-b93d-4d83-942b-485c502db1fa	1
1436239	topiramate 50 MG 24HR Extended Release Oral Capsule	PSN	dbc52b16-b93d-4d83-942b-485c502db1fa	1
1437283	24 HR topiramate 100 MG Extended Release Oral Capsule	SCD	dbc52b16-b93d-4d83-942b-485c502db1fa	1
1437288	24 HR topiramate 200 MG Extended Release Oral Capsule	SCD	dbc52b16-b93d-4d83-942b-485c502db1fa	1
1437278	24 HR topiramate 25 MG Extended Release Oral Capsule	SCD	dbc52b16-b93d-4d83-942b-485c502db1fa	1
1436239	24 HR topiramate 50 MG Extended Release Oral Capsule	SCD	dbc52b16-b93d-4d83-942b-485c502db1fa	1
1437283	topiramate 100 MG 24 HR Extended Release Oral Capsule	SY	dbc52b16-b93d-4d83-942b-485c502db1fa	1
1437288	topiramate 200 MG 24 HR Extended Release Oral Capsule	SY	dbc52b16-b93d-4d83-942b-485c502db1fa	1
1437278	topiramate 25 MG 24 HR Extended Release Oral Capsule	SY	dbc52b16-b93d-4d83-942b-485c502db1fa	1
1436239	topiramate 50 MG 24 HR Extended Release Oral Capsule	SY	dbc52b16-b93d-4d83-942b-485c502db1fa	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
31722-550-30	31722055030	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-550-30)	2026-04-01	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
TOPIRAMATE	Camber Pharmaceuticals, Inc. \| Ascent Pharmaceuticals, Inc.	2026-03-16	HUMAN PRESCRIPTION DRUG LABEL	1